← All organizations
First clinical trial
Aug 1, 2010Last known activity
Oct 1, 2016
Acquired by Alpine Immune Sciences → Vertex → Henry Schein, Inc → Watson Pharmaceuticals → Actavis → Allergan PLC (2015) → AbbVie on Apr 18, 2017
Timeline
2000s
- Jan 1, 2007
Nivalis Therapeutics, Inc.— Founded
2010s
- Apr 18, 2017
Alpine Immune Sciences— Acquired By
- Jun 26, 2019
AbbVie— Now
Drugs by trial phase (5 distinct, 11 trials)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (13)
- NCT02934139Lead sponsorPhase 1Oct 1, 2016
- NCT02724527Lead sponsorPhase 2Apr 1, 2016
- NCT02589236Lead sponsorPhase 2Nov 1, 2015
- NCT02500667Lead sponsorPhase 1Jun 1, 2015
- NCT02275936Lead sponsorPhase 1Feb 1, 2015
- NCT02227888Lead sponsorPhase 1Oct 1, 2014
- NCT02227888Study directorPhase 1Oct 1, 2014
- NCT02013388Study directorPhase 1Feb 1, 2014
- NCT02013388Lead sponsorPhase 1Feb 1, 2014
- NCT01746784Lead sponsorPhase 1Feb 1, 2014
- NCT01339897Lead sponsorPhase 1Apr 1, 2011
- NCT01316315Lead sponsorPhase 1/Phase 2Mar 1, 2011
- NCT01147406Lead sponsorPhase 1Aug 1, 2010
Details
- Founded
- Boulder, CO, US Jan 1, 2007
- Last known activity
- Oct 1, 2016